Compare ECOR & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECOR | VTSI |
|---|---|---|
| Founded | 2005 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1M | 47.5M |
| IPO Year | 2018 | N/A |
| Metric | ECOR | VTSI |
|---|---|---|
| Price | $7.34 | $4.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $22.00 | $7.00 |
| AVG Volume (30 Days) | ★ 97.1K | 58.3K |
| Earning Date | 03-11-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | ★ $29,835,000.00 | $24,934,267.00 |
| Revenue This Year | $28.92 | N/A |
| Revenue Next Year | $40.87 | $13.39 |
| P/E Ratio | ★ N/A | $1,155.71 |
| Revenue Growth | ★ 27.90 | N/A |
| 52 Week Low | $4.16 | $3.57 |
| 52 Week High | $19.49 | $7.47 |
| Indicator | ECOR | VTSI |
|---|---|---|
| Relative Strength Index (RSI) | 61.22 | 49.40 |
| Support Level | $6.40 | $4.54 |
| Resistance Level | $8.30 | $5.19 |
| Average True Range (ATR) | 0.86 | 0.25 |
| MACD | 0.14 | 0.02 |
| Stochastic Oscillator | 71.53 | 40.54 |
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.